Options: Hide MedDRA Preferred Terms
| MedDRA Preferred Term | Side effect | Data for drug | Placebo | Labels | ||
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | ||||
| Anaphylactic shock | Anaphylactic shock | x | ||||
| Angioedema | Angioedema | x | x | |||
| Infection | Infection | x | ||||
| Contusion | Contusion | x | ||||
| Oedema | Oedema | x | x | x | ||
| Exophthalmos | Exophthalmos | x | ||||
| Eye disorder | Eye disorder | x | ||||
| Haemorrhage | Haemorrhage | x | ||||
| Haemoglobin | Haemorrhage | x | ||||
| Hypersensitivity | Hypersensitivity | x | x | x | ||
| Inflammation | Inflammation | x | ||||
| Pain | Pain | x | ||||
| Erythema | Erythema | x | ||||
| Urticaria | Urticaria | x | x | |||
| Periorbital oedema | Periorbital oedema | x | ||||
| Conjunctival oedema | Conjunctival oedema | x | ||||
| Chemosis | x | |||||
| Injection site reaction | Injection site reaction | x | x | |||
| Visual acuity reduced | Visual acuity reduced | x | ||||
| Vision blurred | Vision blurred | x | ||||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||
|---|---|---|---|---|---|---|
| Postpartum haemorrhage | x | |||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |